Your session is about to expire
← Back to Search
Tobacco Cessation Strategies for Smoking
N/A
Waitlist Available
Led By David Wetter
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Participants who speak English or Spanish.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 12 months
Awards & highlights
Study Summary
This trial is testing ways to help people who use tobacco and go to community health centers to quit. They will try different methods and see which ones work best to get people to enroll in the Utah Tobacco Quit Line treatment.
Who is the study for?
This trial is for current tobacco users who visit Community Health Centers or Federally Qualified Health Centers. Participants must have a working cellphone, be able to receive texts and calls, and speak English or Spanish.Check my eligibility
What is being tested?
The study tests strategies to help smokers quit by connecting them with the Utah Tobacco Quit Line treatment through telephone-based support, smoking cessation interventions, and electronic health record prompts.See study design
What are the potential side effects?
Since this trial involves counseling and educational interventions rather than medications, there are no direct physical side effects; however, participants may experience stress or anxiety during the quitting process.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I speak English or Spanish.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Abstinence from tobacco use
Health-related quality of life
Impact
+1 moreSecondary outcome measures
Abstinence from tobacco use (biochemical validation)
Trial Design
5Treatment groups
Experimental Treatment
Group I: Phase II Group II (Text messages continued)Experimental Treatment3 Interventions
Patients receive a monthly text message for 6-12 months following each tobacco user's clinic visit that includes a simple one-touch response to directly connect to the Quitline.
Group II: Phase II Group I (Text messages, Counseling call)Experimental Treatment3 Interventions
Patients receive a monthly text message plus 2 brief telephone calls from patient navigators/health educators for 6-12 months following each tobacco user's clinic visit.
Group III: Phase I Group II (Continued clinic-level EHR intervention only)Experimental Treatment2 Interventions
Patients receive continued clinic level EHR intervention only (CO).
Group IV: Phase I Group I (Continued EHR and text messages)Experimental Treatment3 Interventions
Patients receive a weekly text message for one month followed by a monthly text message over the next 5 months (i.e., 6 months of text messages following each tobacco users' clinic visit). All messages will include a motivational message, the Quit Line website, the Quit Line phone number, and simple two-touch response that directly connects interested tobacco users to the Quit Line.
Group V: Clinic-LevelExperimental Treatment1 Intervention
Clinics will receive the AAC intervention consisting of an EHR-based point of care alert that prompts clinic staff to Ask every patient about tobacco use, Advise tobacco using patients to quit, and Connect interested tobacco users to the Utah Tobacco Quit Line
Assigned Interventions = Electronic Health Record intervention AAC
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Telephone-Based Intervention
2017
Completed Phase 2
~3400
Smoking Cessation Intervention
2005
N/A
~1800
Find a Location
Who is running the clinical trial?
University of UtahLead Sponsor
1,095 Previous Clinical Trials
1,763,576 Total Patients Enrolled
1 Trials studying Tobacco Use
420 Patients Enrolled for Tobacco Use
Patient-Centered Outcomes Research InstituteOTHER
549 Previous Clinical Trials
29,984,767 Total Patients Enrolled
David WetterPrincipal InvestigatorHuntsman Cancer Institute/ University of Utah
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I speak English or Spanish.You are currently smoking or using tobacco products.
Research Study Groups:
This trial has the following groups:- Group 1: Phase I Group II (Continued clinic-level EHR intervention only)
- Group 2: Clinic-Level
- Group 3: Phase I Group I (Continued EHR and text messages)
- Group 4: Phase II Group II (Text messages continued)
- Group 5: Phase II Group I (Text messages, Counseling call)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
To what capacity is this clinical trial accepting participants?
"Absolutely. As indicated by clinicaltrials.gov, this experiment is currently enrolling participants since July 20th 2021 with the last update being on September 26th 2022. In total, 12000 individuals are expected to join from one location."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger